An Australian research team together with international scientists has discovered a new stem cell that can be programmed to become any part of the body.
The ramifications of the find mean that a transplant can be conducted by using the patient's own cells, which can be made into organs and tissue.
The discovery, published in the journal Nature Thursday, is a breakthrough in stem cell research.
"These are remarkably useful cells, because you can apply them to several different areas of medicine," Xinhua quoted molecular biologist Thomas Preiss, from the Australian National University, as telling Fairfax Media.
More than 50 researchers from Australia, Canada, the Netherlands and South Korea worked in the study, known as Project Grandiose, which identified the pluripotent stem cell.
The new cell is considered a potential prototype for the mass production of therapeutic stem cells to treat a huge range of illnesses and injuries.
Medical conditions such as blindness, Parkinson's, Alzheimer's, stroke and spinal cord injury will be major beneficiaries of the new find.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
